Sodium Phenylbutyrate

FDA Approved: * November 18, 2011
Pharm Company: * AMPOLGEN
Category: Hyperammonemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sodium Phenylbutyrate Overview

Sodium phenylbutyrate is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid.[1] The compound is used to treat urea cycle disorders, because its metabolites offer an alternative pathway to the urea cycle to allow excretion of excess nitrogen.[2][3] It is an orphan drug, marketed by Ucyclyd Pharma under the trade name Buphenyl, by Swedish Orphan International (Sweden) as Ammonaps, and by Fyrlklövern Scandinavia...

Read more Sodium Phenylbutyrate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_phenylbutyrate

Recent Sodium Phenylbutyrate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Phenylbutyrate

Powder: 3g/tsp, 3gm/teaspoonful
Tablet: 500mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sodium Phenylbutyrate: (4 results)

Sorted by National Drug Code

42794-086 Sodium Phenylbutyrate .94 g/g Oral Powder by Sigmapharm Laboratories, LLC
46672-851 Sodium Phenylbutyrate 500 mg Oral Tablet by Mikart, Inc.
49884-006 Sodium Phenylbutyrate .94 g/g Oral Powder by Par Pharmaceutical, Inc.
49884-170 Sodium Phenylbutyrate 500 mg Oral Tablet by Par Pharmaceutical, Inc.

Other drugs which contain Sodium Phenylbutyrate or a similar ingredient: (1 result)

BUPHENYL Sodium Phenylbutyrate